Cannara Biotech Inc.
LOVFF
$1.34
-$0.02-1.47%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.95M | 2.32M | 1.68M | 4.20M | 1.48M |
| Total Depreciation and Amortization | 899.50K | 1.14M | 1.13M | 1.29M | 1.11M |
| Total Amortization of Deferred Charges | -- | 28.40K | 24.20K | 14.90K | -- |
| Total Other Non-Cash Items | 1.40M | 1.03M | 1.17M | -3.25M | -1.12M |
| Change in Net Operating Assets | 4.65M | -6.30M | 241.50K | 70.60K | 1.70M |
| Cash from Operations | 9.89M | -1.78M | 4.24M | 2.33M | 3.17M |
| Capital Expenditure | -1.57M | -1.03M | -884.90K | -360.10K | -2.26M |
| Sale of Property, Plant, and Equipment | 11.30K | -- | 2.20K | 8.40K | 1.54M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 38.70K | 50.30K | 29.30K | 33.10K | 28.40K |
| Cash from Investing | -1.52M | -976.00K | -853.30K | -318.60K | -692.90K |
| Total Debt Issued | -- | -- | 500.00K | 0.00 | 2.20M |
| Total Debt Repaid | -1.67M | -162.30K | -599.30K | -572.10K | -3.01M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -747.80K | -1.10M | -920.50K | -1.02M | -235.80K |
| Cash from Financing | -1.72M | -879.80K | -741.30K | -1.16M | -768.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.65M | -3.64M | 2.65M | 844.10K | 1.71M |